Condition
Circadian Rhythm Sleep Disorders
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 2 (1)
Trial Status
Completed3
Suspended1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07385768Not ApplicableCompleted
Effect of an Eye Mask-Based Blackout Protocol on Sleep Quality and Melatonin
NCT02776215Phase 1CompletedPrimary
Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
NCT00490945Phase 2CompletedPrimary
Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
NCT00427323Not ApplicableSuspended
Light Exposure to Treat Sleep Disruption in Older People
Showing all 4 trials